Prophylactic versus therapeutic dose anticoagulation effects on survival among critically ill patients with COVID-19

INTRODUCTION: Although patients with severe COVID-19 are known to be at high risk of developing thrombotic events, the effects of anticoagulation (AC) dose and duration on in-hospital mortality in critically ill patients remain poorly understood and controversial. The goal of this study was to inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoogenboom, Wouter S., Lu, Joyce Q., Musheyev, Benjamin, Borg, Lara, Janowicz, Rebeca, Pamlayne, Stacey, Hou, Wei, Duong, Tim Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769345/
https://www.ncbi.nlm.nih.gov/pubmed/35045130
http://dx.doi.org/10.1371/journal.pone.0262811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769345/
https://www.ncbi.nlm.nih.gov/pubmed/35045130
http://dx.doi.org/10.1371/journal.pone.0262811

Ejemplares similares